We have conducted a randomized, double-blind comparison of 4% and 8% sevoflurane for induction of anaesthesia in unpremedicated patients aged more than 60 yr. Sevoflurane was inhaled in 50% nitrous oxide using a vital capacity breath technique, and mean, systolic and diastolic arterial pressures and heart rate were monitored continuously using a Finapres cuff. In the 8% sevoflurane group, time to successful laryngeal mask insertion was significantly shorter (mean 168 (SD 34) s vs 226 (62) s; PϽ0.01) and achieved more often at the first attempt than in the 4% sevoflurane group. Arterial pressures were lower in the 8% group, but this was not significant. No patient had apnoea lasting longer than 1 min. A total of 69% of patients described induction as pleasant and 85% would choose to have it again. We conclude that compared with 8% sevoflurane, the use of 4% sevoflurane in the elderly resulted in greater cardiovascular stability but at the cost of prolonged and occasionally unsuccessful induction.
Sevoflurane is almost ideal for inhalation induction of anaesthesia. Its properties of a low blood-gas partition coefficient, 1 pleasant smell 2 and a non-irritant effect on the airways 3 allow rapid and smooth induction. 2 Its rapid elimination makes it a particularly useful agent for daycase anaesthesia. 2 Published work on induction with sevoflurane has largely been limited to children and young adults. However, elderly patients also commonly attend as day-cases, and age itself is not a contraindication to day-stay, providing that the patient's general health is good. 4 In young adults, the use of a high concentration of sevoflurane, 5 addition of nitrous oxide 6 and a vital capacity breath technique 7 resulted in rapid induction not usually associated with complications. Induction was accompanied by a reduction in systolic arterial pressure of approximately 20% of pre-induction values. 5 7 8 Elderly patients are more sensitive to the cardiodepressant actions of anaesthetic agents than the young, 9 and the MAC of all inhalation agents decreases with age. 10 Age is a risk factor for perioperative myocardial ischaemia and this is best avoided by minimizing decreases in arterial pressure or large changes in heart rate. 11 
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In this double-blind, randomized, controlled study, we have investigated if 4% or 8% sevoflurane would best achieve smooth inhalation induction of anaesthesia in the elderly, while minimizing cardiovascular side effects.
Patients and methods
After obtaining Ethics Committee approval and written informed consent, we studied 60 patients, aged 60 yr or more, allocated randomly by closed envelope technique to one of two groups. In one group anaesthesia was induced with 4% sevoflurane, and in the other with 8% sevoflurane. Patients received no premedication. All were ASA I-III, undergoing elective urological, orthopaedic or general surgery. Patients receiving drug treatment for cardiovascular disease were excluded, as were those with uncontrolled hypertension, BMI Ͼ35 kg m -2 or severe renal impairment.
Before induction of anaesthesia, an i.v. cannula was inserted and cardiovascular monitoring was commenced with an ECG, oxygen saturation and continuous measurement of systolic, mean and diastolic arterial pressures and heart rate using a Finapres cuff (Ohmeda 2300); in the opposite hand, the patient held a weighted 20-ml syringe above the bed. 12 The sevoflurane vaporizer was set to deliver the randomized concentration of vapour, which was hidden from the view of the investigator by an opaque curtain.
A fresh gas flow of 8 litre min -1 with a gas mix of oxygen and nitrous oxide in a ratio of 1:1 was delivered via a Bain system and an evacuated 4-litre reservoir bag, which were primed until the bag had refilled. Patients breathed room air until induction, which commenced with expiration to residual volume. A clear plastic face mask was then closely fitted to the patient's face and a vital capacity breath taken of the gas mixture, which was held for as long as the patient felt able. A second and third vital capacity breaths were taken if necessary.
Two induction times were measured: from initiation of the first vital capacity breath to dropping the weight; and to successful laryngeal mask insertion. Readiness for the latter was assessed by testing jaw relaxation every 10 s after the weight had been dropped.
Recordings were made of systolic, mean and diastolic arterial pressures, heart rate and oxygen saturation at 1-min intervals, and of the lowest systolic pressure and oxygen saturation values at any time during induction. Recordings were continued for at least 4 min or until successful laryngeal mask insertion. An assessment was made of any induction events and of the patient's performance of the vital capacity breath technique, which was classified as excellent, fair or poor. Induction events were assessed according to the five categories established by Lamberty and Wilson. 13 Coughing, breath-holding, laryngospasm, movement of a limb or excessive salivation was graded as mild, moderate or severe. For all patients, the same blinded investigator (R.W.) was responsible for application of the Finapres cuff, insertion of the laryngeal mask at an appropriate time, and assessment of induction events and patient performance.
In the recovery area, patients completed a questionnaire on their feelings regarding induction, the face mask, the smell of the anaesthetic and if they would choose a similar induction in the future.
Statistical analyses were carried out using the Student's t test, chi-square test and Fisher's exact test, as appropriate. PϽ0.05 was considered as significant.
Results
Data from one patient in each group were excluded from analysis because of deviations from the study procedure; therefore, there were 29 patients in each group. Patient characteristics in the two groups were comparable (Table 1) .
Induction times
The weight was dropped more rapidly by the 8% sevoflurane group compared with the 4% sevoflurane group (mean 112 (SD 34) s vs 138 (58) s), although this difference was not statistically significant. Most patients became unresponsive 21 to command and resumed tidal ventilation well before the syringe was dropped. Successful laryngeal mask insertion was achieved significantly more rapidly in the 8% sevoflurane group (mean 168 (34) s vs 226 (62) s; PϽ0.01).
Induction with sevoflurane was achieved in all patients in the 8% group. Two patients in the 4% sevoflurane group required 'rescue' i.v. induction: one because of involuntary movements to the extent that he could not be restrained safely and the other because of a prolonged, eventful induction continuing 6 min later.
An unsuccessful first attempt at laryngeal mask insertion occurred in six patients in the 4% sevoflurane group. Only one patient in the 8% sevoflurane group failed to accept the laryngeal mask on the first attempt; this was caused by a difficult airway rather than inadequate anaesthesia, and the laryngeal mask was eventually placed with the aid of a laryngoscope.
One or more induction events occurred in 19 patients in each group, but there was no significant difference between groups for any event ( Table 2 ). The most frequent event was breath-holding, but in no patient did apnoea continue for longer than 1 min, and none required assistance with ventilation. Laryngospasm and coughing each occurred in eight patients, and more of these were in the 4% sevoflurane group. In most patients, these events were associated with laryngeal mask insertion, classified as mild, and resolved rapidly with deepening of anaesthesia and/or adjustment of the mask position. In no patient was oxygenation impaired or assistance with ventilation required.
The lowest oxygen saturation recorded was less than 94% in only four patients. One patient in the 4% sevoflurane group had a minimum saturation of 88%, but this value had also been recorded, breathing air, before operation. In the 8% sevoflurane group, three patients had minimum oxygen saturations of 88%, 91% and 93%, respectively; in each case, the period of low saturation was brief and no intervention was required.
Arterial pressure and heart rate
Preoperative arterial pressure (recorded by the nursing staff on admission to the ward) varied widely, although mean and range values were similar in the two groups ( Table 1) . Because of the variation in initial arterial pressures, we expressed all arterial pressure changes during induction as a proportion of pre-induction values. Pre-induction measurements were made using the Finapres cuff and were similar between groups (Table 1 ). The minimum systolic arterial pressure during induction was lower in the 8% sevoflurane group, with a mean reduction from pre-induction pressure of 30 (13)%. This was not significantly different from the mean minimum pressure in the 4% sevoflurane group (25 (13)% reduction from pre-induction values) (Fig. 1) .
When systolic pressures were considered for each minute of induction, these were consistently lower in the 8% sevoflurane group (Fig. 1) . However, at no time was the difference significant. Changes in mean and diastolic arterial pressures were similar to systolic pressure. There was no significant difference between groups. Mean heart rate remained almost unchanged during induction in both groups, with no significant difference at any time (Fig. 2) .
Patient performance and satisfaction
Most patients were judged to have complied well with the vital capacity technique, with the majority of performances classified as excellent, and only three as poor. There was no significant difference in patient performance between groups.
Patients were generally satisfied with this method of induction, and their responses to the postoperative questionnaire are shown in Table 3 . Patient satisfaction was not significantly different between groups.
Discussion
Our results suggest that a vital capacity technique combining nitrous oxide and sevoflurane in unpremedicated elderly patients provided an induction that was safe, practical and pleasant. Induction times were shorter in the group who received 8% sevoflurane, and inhalation induction was achieved in all patients in this group, compared with two in the 4% sevoflurane group in whom it had to be abandoned. Failed laryngeal mask insertion was also more common in the 4% sevoflurane group. Induction events were common in both groups, but were generally minor and did not significantly interfere with inhalation induction of anaesthesia. Elderly patients have a high incidence of clinical and occult coronary artery disease and age is a major risk factor for perioperative cardiac morbidity. This risk may be minimized by maintenance of a balance between myocardial oxygen supply and demand. During the perioperative period, this balance is best preserved by avoidance of periods of significant hypotension, hypertension or tachycardia. 11 In our patients, reduction in arterial pressure in the 8% sevoflurane group was greater than that in the 4% sevoflurane group. The difference between groups was not significant at any stage, but the small difference that we showed may be clinically significant in a population at risk of myocardial ischaemia. Furthermore, it is possible that a larger study may have detected a statistically significant difference between groups. It should be noted, however, that the maximum difference between the two groups occurred 4 min after induction had commenced. In the 8% sevoflurane group, laryngeal mask insertion occurred in a mean time of 2 min 48 s, and therefore in the clinical setting, sevoflurane concentration would probably have been reduced at this stage, allowing arterial pressure to recover earlier. We administered sevoflurane at the randomized concentration for at least 4 min and this may have artificially increased the difference between the two groups.
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In contrast, we have shown that there was very little change in heart rate during sevoflurane induction in this population.
The Finapres is a non-invasive monitor which provides beat-to-beat information on systolic, mean and diastolic arterial pressures and heart rate via a cuff around the middle phalanx of one digit. Measurements obtained simultaneously by arterial cannula and Finapres show small differences in arterial pressure, usually of the order of several mm Hg. 14 Although not a replacement for an arterial cannula, the Finapres is therefore useful in situations where arterial pressure may change rapidly but an arterial cannula is not justified. 15 Patients receiving medication for hypertension or cardiovascular disease were excluded from this investigation as these drugs may influence changes in arterial pressure at induction of anaesthesia. 16 17 However, many elderly patients are receiving one or more of these drugs, and more work is required to investigate how the behaviour of this group differs from that of our patients.
Drugs such as tamsulosin (Flomax) are selective α-blockers which are used to improve urinary flow in benign prostatic hypertrophy. They also have an antihypertensive action 16 and it is possible that such agents, in common with other antihypertensive medications, may be responsible for a greater reduction in arterial pressure at induction than would otherwise be expected. Three of our patients were receiving tamsulosin. Only one of these was randomized to the 8% sevoflurane group, but at induction his systolic arterial pressure decreased to a greater extent than any other patient in the group. We decided to exclude from analysis the cardiovascular data of these three patients, although it is interesting to note that the behaviour of the two patients on tamsulosin who were randomized to the 4% sevoflurane group was similar to that of other patients in this group.
A common choice of induction agent for day-case anaesthesia is propofol. Thwaites, Edmends and Smith compared 8% sevoflurane with propofol for induction of unpremedicated adults of all ages and found that propofol resulted in more rapid induction but with a greater reduction in arterial pressure. 8 Elderly patients are particularly sensitive to hypotension after propofol induction, although this can be minimized by giving the injection slowly. 18 In one study of elderly patients not receiving cardiac medications, propofol induction resulted in a mean reduction in systolic arterial pressure of 19-27% at 2 min. 19 Compared with our patients, this is a similar or greater reduction in arterial pressure; however, patients in the above investigation were premedicated with temazepam and pretreated with fentanyl. We are not aware of any study directly comparing propofol with sevoflurane in the elderly.
In the 1990s, consideration of cost must also play some part in the anaesthetist's choice of induction agent. Sevoflurane is generally considered to be an expensive agent, but two studies comparing it with propofol have concluded that sevoflurane is the cheaper option for induction. 6 8 Most studies of sevoflurane induction from Britain and the USA have used preoxygenation. 6 8 In studies from Japan, however, patients breathed room air before induction, and oxygenation remained excellent throughout. 5 7 The use of the vital capacity breath technique requires thorough priming of the breathing system, and any preoxygenation must therefore involve an additional source of oxygen and a second breathing system. Our results showed that even in an elderly population, oxygen saturation was well maintained throughout induction with sevoflurane in 50% nitrous oxide. This is probably because of the presence of a vital capacity volume of 50% oxygen in the lungs as induction begins, and the low incidence of significant respiratory events using this technique.
In the postoperative questionnaire, two-thirds of patients described induction with sevoflurane as a pleasant experience, and only one patient said that it had been unpleasant. Patient satisfaction with the technique was also reflected in the 85% of patients who stated that if a choice was offered, they would choose sevoflurane induction in future. Regarding the smell of sevoflurane, our patients were divided almost equally between 'pleasant' and 'neutral'. This contrasts markedly with the findings of a study in adults of all ages, in which 29% of patients undergoing sevoflurane induction described the smell as unpleasant. 8 The majority of patients had no problems understanding and performing the vital capacity breath technique. When this technique was described originally for halothane in oxygen, 20 young adults held the initial breath for 30-90 s before resuming tidal ventilation. We felt that elderly patients might have difficulty holding a breath for 30 s or more. Therefore, we modified the technique to allow a second and third vital capacity breath if required.
In summary, our results suggest that in an elderly population not receiving cardiovascular medications, sevoflurane 24 in 50% nitrous oxide by a vital capacity breath technique provided induction that was practical, safe and liked by patients. Compared with 8%, the use of 4% sevoflurane resulted in greater cardiovascular stability but at the cost of a more prolonged, eventful and occasionally unsuccessful induction. Comparison with other studies suggests that in terms of cost and cardiovascular stability, sevoflurane induction compares favourably with propofol in this age group.
